Literature DB >> 12116369

Detection and relocation of cord blood nucleated red blood cells by laser scanning cytometry.

Simone Hennerbichler1, Rudolf Schmied, Erwin Petek, Peter M Kroisel, Barbara Pertl, Beate Tiran, Gottfried Dohr, Reinhold Wintersteiger, Peter Sedlmayr.   

Abstract

BACKGROUND: Fetal nucleated red blood cells (NRBC) present in the peripheral blood of pregnant women at low frequency are a potential target for noninvasive prenatal diagnostics.
METHODS: CD71-enriched cells from male cord blood (CB) were stained for the gamma chain of HbF (Hb-gamma) and cytocentrifuged. Fluorescence in situ hybridization (FISH) was done for the Y chromosome. Following staining of the nucleus with TO-PRO-3, laser scanning cytometry was performed. Artificial mixtures of small volumes of male CB and blood drawn from nonpregnant females were analyzed.
RESULTS: In CB, 59% of events double positive for Hb-gamma and TO-PRO-3 were identified as CB-NRBC. In contamination studies, male fetal CB-NRBC were identified perfectly on the basis of morphologic characteristics and FISH reactivity following relocation and visual assessment. Mean recovery was 8.7%.
CONCLUSIONS: Laser scanning cytometry of preenriched fetal NRBC may offer a promising way for noninvasive prenatal diagnostics. This is because it provides a virtual enrichment step and the position on the slides of cells visually confirmed to correspond to fetal NRBC is known. Further experimental procedures on well-defined and located target cells may be feasible. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12116369     DOI: 10.1002/cyto.10112

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  1 in total

1.  Automatic retrieval of single microchimeric cells and verification of identity by on-chip multiplex PCR.

Authors:  Thomas Kroneis; Liat Gutstein-Abo; Kristina Kofler; Michaele Hartmann; Petra Hartmann; Marianna Alunni-Fabbroni; Wolfgang Walcher; Gottfried Dohr; Erwin Petek; Esther Guetta; Peter Sedlmayr
Journal:  J Cell Mol Med       Date:  2009-05-19       Impact factor: 5.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.